Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royal Bank of Canada (NY:RY)

145.79 +0.48 (+0.33%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Royal Bank of Canada

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
30 31 Next >
Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug
The company reported a strong start for its newest drug, Crenessity, which treats a hormonal disorder involving the adrenal glands. 
Via Investor's Business Daily
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks
The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program. 
Via Investor's Business Daily
Topics Government Intellectual Property
Analysts Still Like Chevron, Cite Strong FCF & Balance Sheet As Key Amid OPEC And Recession Fears
B of A Securities analyst maintains Buy rating on Chevron Corp. despite mixed Q1 earnings. Reiterates attractive investment due to strong cash flow and financial position. RBC Capital Markets also... 
Via Benzinga
Topics Economy
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Files Amended $700M Market Manipulation Complaint in Federal Court
Via Investor Brand Network
Diamondback Energy Q1 Preview: Investors Eyeing Production Forecast Amid Oil Price Drop, Retail’s Divided
Wall Street expects the oil and gas producer to post adjusted earnings of $4.20 per share on revenue of $3.75 billion. 
Via Stocktwits
Topics World Trade
2 Profitable Stocks with Promising Prospects and 1 to Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Cybersecurity Stocks: Artificial Intelligence Dominates RSA Conference But Monetization Still In Question
The RSA conference this week didn't deliver much breaking news on cybersecurity stocks but Wall Street analysts came away upbeat on industry trends. 
Via Investor's Business Daily
Topics Artificial Intelligence
2 Cash-Producing Stocks with Competitive Advantages and 1 to Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Price Over Earnings Overview: RBC Bearings
 
Via Benzinga
Palantir's Government, Commercial Business Trends Eyed In Q1 Earnings
Palantir reports Q1 earnings on Monday, the data analytics software maker's government and commercial businesses will again be in focus. 
Via Investor's Business Daily
Topics Artificial Intelligence Earnings
Here's How Much $100 Invested In RBC Bearings 15 Years Ago Would Be Worth Today
 
Via Benzinga
Visa's Q2 Results Reflect Steady US Spending Despite Market Uncertainty: Analyst Highlights Strength In Payment Volumes
Visa gains after RBC's Perlin highlights strong Q2 results, steady U.S. spending, and a $30B buyback plan. 
Via Benzinga
BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations
The company sells a rival to Pfizer' heart treatment, Vyndaqel. Sales smashed expectations in its first quarter on the market. 
Via Investor's Business Daily
1 Industrials Stock to Consider Right Now and 2 to Approach with Caution
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence... 
Via StockStory
Topics Stocks
DoorDash's Deliveroo Offer Seen As 'Meaningfully Expanding' Global Reach
DoorDash stock analysts were mostly positive on the company's offer to acquire U.K.-focused food delivery firm Deliveroo. 
Via Investor's Business Daily
CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug
The companies are working on treatments for a form of bladder cancer. 
Via Investor's Business Daily
Did Google Earnings Results Put Search Worries To Rest? Here's What Analysts Are Saying
Google stock climbed on better-than-expected Q1 earnings and search ad revenue as management touted the new AI Overviews format. 
Via Investor's Business Daily
Topics Artificial Intelligence
Unpacking Q4 Earnings: RBC Bearings (NYSE:RBC) In The Context Of Other Engineered Components and Systems Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at RBC Bearings (NYSE:RBC) and the best and... 
Via StockStory
The Market and Fed Chair Powell
Fed independence brings stability, and markets love stability. 
Via The Motley Fool
Topics Economy Government
Google Earnings Due. Here's What Could Move Alphabet Stock.
Google stock has retreated 20% in 2025 heading into Alphabet's Q1 earnings report. Google's internet search business is still top of mind for investors amid the rise of generative artificial... 
Via Investor's Business Daily
Topics Artificial Intelligence Economy
Danaher Makes A Bullish Move On 'Solid' Report, Promising Tariffs Plan
The company's commentary on tariffs was a "pleasant surprise," according to one analyst. 
Via Investor's Business Daily
Topics Economy Government World Trade
Are Hospital Stocks At Risk Amid Medicaid Funding Fears? RBC Downplays Worries While Retail Eyes Q1 Results
The Wall Street Journal highlighted UHS, THC and HCA as key beneficiaries of Medicaid supplemental payment programs that cost the federal government hundreds of billions. 
Via Stocktwits
Topics Government
Chipotle Mexican Grill Q1 Preview: Retail Gets Bullish As Traders Eye Tariff Commentary, Expansion Plans
The burrito chain has maintained that it will not increase the prices of its menu items and will offset higher input costs through automation and other initiatives. 
Via Stocktwits
Topics World Trade
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly. 
Via Investor's Business Daily
Topics Government
American Express' Solid Revenue, Spending Trends Drive Analyst Optimism
RBC analyst maintains Outperform rating on American Express (AXP) with $310 price target. AXP reports strong Q1 2025 results, reaffirms revenue and EPS outlook. 
Via Benzinga
Looking Into RBC Bearings's Recent Short Interest
 
Via Benzinga
3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade
Consider buying these top-notch AI-powered stocks in the current market dip. 
Via The Motley Fool
Topics Artificial Intelligence
Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It
The companies are facing off with their heart drugs in a growing disease area. 
Via Investor's Business Daily
We Asked Retail Traders Where Tesla's Next 20% Move Is — Most Say ‘Higher’ Despite Growing Short Interest
Optimists think a bad earnings report is already priced in and hope CEO Elon Musk will soon announce his exit from Trump’s administration. 
Via Stocktwits
Topics Bankruptcy Electric Vehicles Government
Canadian Banks Ranking 2025 – Which Bank To Hold?
Whether you already hold one of these financial giants or are considering adding a bank to your portfolio, this will help you understand key strengths, weaknesses, and long-term investment potential. 
Via Talk Markets
Topics Stocks / Equities
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.